Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Shattuck Labs Inc (STTK)

Shattuck Labs Inc (STTK)
0.8900 x 50 0.9400 x 20
Post-market by (Cboe BZX)
0.8931 +0.1031 (+13.05%) 04/22/25 [NASDAQ]
0.8900 x 50 0.9400 x 20
Post-market 0.8901 -0.0030 (-0.34%) 18:21 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.7600
Day High
0.9000
Open 0.8200
Previous Close 0.7900 0.7900
Volume 169,500 169,500
Avg Vol 308,120 308,120
Stochastic %K 15.53% 15.53%
Weighted Alpha -70.45 -70.45
5-Day Change +0.0149 (+1.70%) +0.0149 (+1.70%)
52-Week Range 0.6922 - 11.7600 0.6922 - 11.7600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,605
  • Shares Outstanding, K 47,899
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -75,410 K
  • EBIT $ -80 M
  • EBITDA $ -78 M
  • 60-Month Beta 1.76
  • Price/Sales 6.47
  • Price/Cash Flow N/A
  • Price/Book 0.46
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.53
  • Most Recent Earnings $-0.37 on 03/27/25
  • Next Earnings Date 05/01/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 361.62% ( -115.35%)
  • Historical Volatility 224.93%
  • IV Percentile 79%
  • IV Rank 40.22%
  • IV High 884.45% on 04/04/25
  • IV Low 9.84% on 08/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 30
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 193
  • Open Int (30-Day) 166

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 3
  • High Estimate -0.22
  • Low Estimate -0.40
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +21.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6922 +28.58%
on 04/07/25
Period Open: 1.2000
1.4900 -40.27%
on 04/07/25
-0.3100 (-25.83%)
since 03/21/25
3-Month
0.6922 +28.58%
on 04/07/25
Period Open: 1.1200
1.9400 -54.12%
on 02/25/25
-0.2300 (-20.54%)
since 01/22/25
52-Week
0.6922 +28.58%
on 04/07/25
Period Open: 9.3000
11.7600 -92.43%
on 05/14/24
-8.4100 (-90.43%)
since 04/22/24

Most Recent Stories

More News
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

STTK : 0.8900 (+13.36%)
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

STTK : 0.8900 (+13.36%)
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

STTK : 0.8900 (+13.36%)
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

STTK : 0.8900 (+13.36%)
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress

STTK : 0.8900 (+13.36%)
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

STTK : 0.8900 (+13.36%)
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

STTK : 0.8900 (+13.36%)
Shattuck Labs, Inc. to Present at Piper Sandler and Evercore Investor Conferences in December 2024

Shattuck Labs will present at two investor conferences in December 2024, focusing on its novel cancer and autoimmune disease therapeutics.Quiver AI SummaryShattuck Labs, Inc., a biotechnology company focused...

STTK : 0.8900 (+13.36%)
Shattuck Labs Announces Participation in Upcoming December Conferences

STTK : 0.8900 (+13.36%)
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights

STTK : 0.8900 (+13.36%)

Business Summary

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North...

See More

Key Turning Points

3rd Resistance Point 1.0800
2nd Resistance Point 0.9900
1st Resistance Point 0.9400
Last Price 0.8900
1st Support Level 0.8000
2nd Support Level 0.7100
3rd Support Level 0.6600

See More

52-Week High 11.7600
Fibonacci 61.8% 7.5321
Fibonacci 50% 6.2261
Fibonacci 38.2% 4.9201
Last Price 0.8900
52-Week Low 0.6922

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro